2,479 results on '"Hand, Foot and Mouth Disease"'
Search Results
2. Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option
3. Surveillance of HFMD in Pediatric Outpatients (PMB)
4. Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia
5. Evolving pathogen trends and spatial–temporal dynamics of hand, foot, and mouth disease in Fengxian District, Shanghai (2009–2022).
6. Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study.
7. Evolving pathogen trends and spatial–temporal dynamics of hand, foot, and mouth disease in Fengxian District, Shanghai (2009–2022)
8. Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
9. Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
10. Analysis of epidemiological characteristics of the clustered cases of hand, foot and mouth disease in Pudong New Area, Shanghai, 2017‒2022
11. La enfermedad de mano, pie y boca en niños: una revisión sistemática.
12. Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease.
13. Effects of extreme meteorological factors and high air pollutant concentrations on the incidence of hand, foot and mouth disease in Jining, China.
14. A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
15. A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
16. A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants
17. The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
18. Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
19. Independent and interactive effects of particulate matter and meteorological factors on hand, foot and mouth disease in Fuyang
20. Impact of the COVID-19 outbreak and interventions on hand, foot and mouth disease in Zhengzhou, China, 2014–2022: a retrospective study
21. Impact of the launch of EV71 vaccination on prevalence characteristics and pathogen spectrum of severe hand, foot and mouth disease in Henan province, 2014 – 2020: a register data analysis
22. Epidemiological characteristics and influencing factors of hand, foot, and mouth disease outbreaks in Jiangsu province, 2010 – 2022: a register data analysis
23. Advances in anti-EV-A71 drug development research
24. Impact of the COVID-19 outbreak and interventions on hand, foot and mouth disease in Zhengzhou, China, 2014–2022: a retrospective study.
25. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
26. Advances in anti-EV-A71 drug development research.
27. Role of nonlinear transmission term in stability of hand, foot and mouth disease dynamics.
28. Effects of extreme meteorological factors and high air pollutant concentrations on the incidence of hand, foot and mouth disease in Jining, China
29. Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study
30. TRATAMENTO DE MANIFESTAÇÃO BUCAL EXACERBADA DA DOENÇA DE MÃO, PÉ E BOCA COM APDT.
31. Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity
32. The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine
33. Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai
34. An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
35. A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
36. Clinical Trial of Enterovirus 71(EV71) Inactivated Vaccine in Children Aged 36-71 Months
37. Spatiotemporal associations between hand, foot and mouth disease and meteorological factors over multiple climate zones.
38. 手足口病患儿血清 FGF-21 与 GDF-15 水平检测的 临床诊疗应用研究.
39. Factors related to the mortality risk of severe hand, foot, and mouth diseases (HFMD): a 5-year hospital-based survey in Guangxi, Southern China
40. Epidemiological characteristics of hand, foot and mouth disease in Shenzhen from 2008 to 2020 and effect of inactivated EV71 vaccine on disease incidence
41. Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial
42. Impact of meteorological factors on the incidence of hand-foot-mouth disease in Yangzhou from 2017 to 2022: a time series study
43. 广西2014—2018年重症手足口病空间流行特征.
44. Immune Efficacy of the EV71 Vaccine in Fujian Province, China: A Real-World Analysis of HFMD.
45. Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines
46. Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines
47. Efficacy Trial of a Commercial EV71 Vaccine
48. Immunogenicity and Safety of Two Different Commercial EV71 Vaccines
49. Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children
50. Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.